Moreno-Ajona, David http://orcid.org/0000-0002-0366-5994
Hoffmann, Jan http://orcid.org/0000-0002-2103-9081
Akerman, Simon http://orcid.org/0000-0002-6577-6825
Article History
Accepted: 23 January 2022
First Online: 11 February 2022
Compliance with Ethical Standards
:
: David Moreno Ajona reports no conflict of interest. Jan Hoffmann received personal fees for consulting, serving on advisory fees and/or speaking for Allergan, Autonomic Technologies Inc., Cannovex BV, Chordate Medical AB, Eli Lilly, Hormosan Pharma, Lundbeck, Novartis Pharma, Sanofi and Teva. He also received personal fees for Medico-Legal work as well as from Oxford University Press, Quintessence Publishing, Sage Publishing and Springer Healthcare. He receives research support from Bristol Myers Squibb. All these activities are unrelated to the submitted work. Simon Akerman reports personal fees from Amgen, Allergan, and Kallyope, and for Patent/Legal work in headache and orofacial pain, unrelated to this work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.